about
Use of a bacteriophage lysin to identify a novel target for antimicrobial developmentWhole-genome sequencing targets drug-resistant bacterial infectionsTranscriptional profiles of the response of methicillin-resistant Staphylococcus aureus to pentacyclic triterpenoidsStrong antibiotic production is correlated with highly active oxidative metabolism in Streptomyces coelicolor M145High-frequency transposition for determining antibacterial mode of action.Antibiotic acyldepsipeptides activate ClpP peptidase to degrade the cell division protein FtsZProteomic response of Bacillus subtilis to lantibiotics reflects differences in interaction with the cytoplasmic membrane.Biological roles of cysteine proteinases in the pathogenesis of Trichomonas vaginalis.The evolving role of chemical synthesis in antibacterial drug discovery.Novel classes of antibiotics or more of the same?Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogensTarget mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in mycobacteriaDiscovery of phosphonic acid natural products by mining the genomes of 10,000 actinomycetes.Genetic Approaches to Facilitate Antibacterial Drug Development.Changing trend of antimicrobial resistance among pathogens isolated from lower respiratory tract at a university-affiliated hospital of China, 2006-2010.Targeting iron assimilation to develop new antibacterials.Multiplexed integrating plasmids for engineering of the erythromycin gene cluster for expression in Streptomyces spp. and combinatorial biosynthesis.Biological evaluation of benzothiazole ethyl urea inhibitors of bacterial type II topoisomerases.How to cope with the quest for new antibiotics.Proteomic signatures in antibiotic research.Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs.Bacterial type I signal peptidases as antibiotic targets.Antimicrobial enzymes: an emerging strategy to fight microbes and microbial biofilms.Natural products for pest control: an analysis of their role, value and future.In vitro biological evaluation of novel broad-spectrum isothiazolone inhibitors of bacterial type II topoisomerases.Employing the promiscuity of lantibiotic biosynthetic machineries to produce novel antimicrobials.Antimicrobial and anti-biofilm activity of tannic acid against Staphylococcus aureus.Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus.Generation of a vancomycin-intermediate Staphylococcus aureus (VISA) strain by two amino acid exchanges in VraS.Mining antimicrobial peptides from small open reading frames in Ciona intestinalis.Effects of the antimycobacterial compound 2-phenoxy-1-phenylethanone on rat hepatocytes and formation of metabolites.Actinomycetes: still a source of novel antibiotics.Activity-Based Protein Profiling in Bacteria.A simple, robust enzymatic-based high-throughput screening method for antimicrobial peptides discovery against Escherichia coli.2-D Gel-Based Proteomic Approaches to Antibiotic Drug Discovery
P2860
Q21133592-47F37800-789E-4B36-91FA-E1CB9C0705C1Q26799059-626EA5F4-0CFB-4AEC-AD66-984D320419C3Q28486248-D01BC276-FDA2-4EC4-BC17-C96C6095E4BAQ33669799-134649B7-3E53-4695-BEC6-A0BED6ECD77AQ34011008-25D4044A-155A-4AD5-90A8-DCC5D3AF36ADQ34221202-D48F049C-C2F8-43E4-8663-2D5ED979B90DQ34394918-72202F0B-4A20-4EF3-86AB-1F064D798950Q34406802-6E81732E-04E5-4299-BF00-CA3952F81DC4Q34427652-051D7229-7999-4FE1-9267-A9CA26D64FAEQ34903245-BEBE5741-0B2F-4753-A8EA-7D13DEFF4190Q35561864-9F4C703B-827D-4DAD-83E1-57557686EB5AQ35620201-33B234D9-7CE4-4C24-9E1A-5207965892F9Q35760776-BBF47BEF-A195-4C53-9E8B-7561C256E4B8Q35795582-F6621266-8C04-464C-B662-1D1AA3A341B9Q36042237-2CDDC4F5-7AA0-4356-8111-2FCBF2805971Q36211648-D809D973-8ADE-4088-BE06-D3F35BC94187Q36279519-FA2EA7DD-2BFC-4B97-AEF2-2E1C14BC5F79Q37335706-3C9E109B-B39F-42E4-82AF-5B5A68306E41Q37868070-C43EDB4A-FE28-4C25-B1D4-DDDE8E5FADD1Q37897212-A1669E39-FF5D-4CDA-A66A-BD536CED3AA3Q37909413-EC833D92-A44B-4C64-B881-922BF0A1326DQ37955948-1C71E35B-24B1-4EAB-A087-7E80710906D5Q38071062-B5DD6658-1B99-44C7-A0C5-23C793BD6454Q38183347-84B96C66-B5DB-422D-904E-3F34C0EF1E1FQ38761164-F7DE9D78-E4A4-49AF-B331-DA9A97287805Q38945513-4A3F9DDC-DACB-4FD8-8B54-B68F1CBE2D1EQ40085794-8D6FAE8B-CB46-492A-A87D-C5DE60C6F709Q40718746-126EDC12-323A-4ACC-85CF-A7D3DCEDD3D5Q42202739-0926E389-72A3-4BA3-8C3A-112158EEC7AFQ42629096-694BEA0E-CE15-43ED-9BE4-D603B2486876Q44533152-7C7A3789-0D75-4DC9-AA21-51365A90071FQ46319269-6E6CDE19-4760-4B6F-BCB2-088698CDCBB5Q51364812-75CBB1D2-C88B-46F9-93C1-888D40541E79Q52648691-410795D2-F91F-4D61-A8BF-CF30531AA0ACQ58916049-9975AD12-E922-4DA4-88A3-EB1FFDBAA7DB
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Postgenomic strategies in antibacterial drug discovery.
@ast
Postgenomic strategies in antibacterial drug discovery.
@en
type
label
Postgenomic strategies in antibacterial drug discovery.
@ast
Postgenomic strategies in antibacterial drug discovery.
@en
prefLabel
Postgenomic strategies in antibacterial drug discovery.
@ast
Postgenomic strategies in antibacterial drug discovery.
@en
P2860
P356
P1433
P1476
Postgenomic strategies in antibacterial drug discovery
@en
P2093
Heike Brötz-Oesterhelt
P2860
P304
P356
10.2217/FMB.10.119
P50
P577
2010-10-01T00:00:00Z